COHR Stock Charts

Quarterly

Annual

Unit: USD	2022-04-02	2022-01-01	2021-10-02	2021-07-03	2021-04-03	2021-01-02	2020-10-03	2020-07-04	2020-04-04	2019-12-28	2019-09-28	2019-06-29	2019-03-30	2018-12-29	2018-09-29	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2017-07-01	2017-04-01	2016-12-31	2016-10-01	2016-07-02	2016-04-02	2016-01-02	2015-10-03	2015-07-04	2015-04-04	2014-12-27	2014-09-27	2014-06-28	2014-03-29	2013-12-28	2013-09-28	2013-06-29	2013-03-30	2012-12-29	2012-09-29	2012-06-30	2012-03-31	2011-12-31	2011-10-01	2011-07-02	2011-04-02	2011-01-01	2010-07-03	2010-04-03	2010-01-02	2009-07-04	2009-04-04	2008-12-27	2008-06-28	2008-03-29	2007-12-29	2006-12-30	2005-12-31	2005-01-01	2004-07-03	2004-04-03	2003-12-27	2003-09-30	2003-06-28	2003-03-29	2002-12-28	2001-12-29

cash flows from operating activities:
net income	33,676,000	30,265,000	21,058,000	30,262,000	-158,215,000	144,000	7,689,000	-8,708,000	-418,913,000	5,793,000	624,000	-3,099,000	20,750,000	35,550,000	73,185,000	66,970,000	65,302,000	41,901,000	73,752,000	61,117,000	41,845,000	30,408,000	30,785,000	18,650,000	17,781,000	20,286,000	27,302,000	13,264,000	18,413,000	17,430,000	19,097,000	12,999,000	15,307,000	11,703,000	20,515,000	16,685,000	15,002,000	14,153,000	12,548,000	17,208,000	16,155,000	17,051,000	31,380,000	19,022,000	23,723,000	19,113,000	14,404,000	8,480,000	4,179,000	-7,015,000	-9,130,000	-14,679,000	8,402,000	6,125,000	4,729,000	10,758	9,316,000	5,391,000			-306,000			1,927,000	-20,483,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	11,763,000	11,026,000	11,424,000	11,224,000	10,984,000	10,606,000	10,448,000	10,325,000	12,776,000	13,156,000	13,463,000	13,772,000	13,774,000	13,916,000	14,607,000	13,336,000	12,844,000	12,555,000	12,113,000	11,618,000	10,963,000	8,995,000	6,495,000	6,527,000	6,498,000	6,385,000	6,362,000	6,017,000	6,226,000	6,210,000	6,602,000	6,482,000	6,825,000	6,699,000	6,970,000	6,599,000	6,679,000	6,108,000	6,064,000	5,673,000	5,678,000	5,828,000	5,686,000	5,136,000	4,950,000	4,767,000	5,032,000	5,923,000	5,752,000	4,652,000	4,987,000	4,729,000	5,436,000	6,260,000	5,981,000	6,220	6,485,000	7,310,000	7,295,000	8,447,000	6,859,000	7,871,000	7,174,000	7,020,000	6,937,000	5,480,000
amortization of intangible assets	830,000	1,383,000	2,559,000	3,109,000	2,451,000	2,614,000	2,962,000	2,947,000	11,907,000	12,312,000	13,735,000	18,626,000	14,032,000	15,067,000	14,401,000	15,209,000	15,329,000	15,100,000	16,253,000	15,452,000	16,763,000	12,088,000	2,249,000	2,032,000	2,077,000	2,092,000	2,068,000	1,960,000	2,036,000	2,180,000	2,312,000	2,402,000	2,434,000	2,445,000	2,454,000	2,724,000	3,408,000	1,181,000	1,436,000	1,723,000	1,611,000	1,636,000	1,879,000	1,851,000	2,257,000	2,095,000	2,041,000	1,956,000	1,961,000	1,907,000	1,894,000	1,943,000	2,165,000	2,229,000	2,206,000	1,943	2,306,000
deferred income taxes	4,456,000	-4,070,000	-5,268,000	-1,734,000	-56,207,000	12,615,000	-2,674,000	2,814,000	-22,700,000	-1,911,000	-6,721,000	-3,756,000	-2,948,000	-1,505,000	-1,773,000	4,301,000	958,000	13,121,000	-21,716,000	7,584,000	-6,911,000	1,291,000	-6,414,000	2,297,000	-2,161,000	-3,492,000	-4,474,000	-1,171,000	-505,000	6,988,000	-5,070,000	-1,037,000	-457,000	-1,621,000	-882,000	2,475,000	-2,425,000	-275,000	-2,668,000	-2,186,000	618,000	-527,000	4,840,000	9,070,000	83,000	8,096,000	2,545,000	4,456,000	6,921,000								2,760,000	3,393,000	-5,534,000	5,954,000	2,012,000	-10,483,000
amortization of debt issuance cost	676,000	748,000	868,000	870,000	884,000	857,000	870,000	807,000	818,000	826,000	837,000	1,248,000	1,274,000	1,288,000	1,314,000	1,030,000	3,406,000	3,815,000	4,232,000	1,263,000	1,107,000	600,000
(gain) loss on sale of assets
stock-based compensation	9,043,000	31,907,000	9,980,000	10,148,000	9,092,000	12,185,000	13,711,000	14,386,000	8,898,000	7,792,000	9,931,000	9,655,000	9,004,000	7,876,000	8,669,000	8,583,000	8,410,000	7,076,000	7,194,000	6,892,000	6,683,000	5,503,000	5,336,000	5,689,000	5,387,000	3,745,000	4,495,000	4,565,000	4,782,000	4,390,000	4,690,000	4,667,000	4,672,000	4,868,000	4,615,000	4,640,000	4,642,000	4,994,000	4,005,000	4,127,000	4,161,000	4,022,000	3,442,000	3,437,000	3,162,000	2,922,000	2,191,000	2,018,000	1,874,000	1,488,000	2,425,000	1,753,000	1,605,000	3,051,000	2,260,000	3,491	3,047,000
non-cash restructuring charges	-13,000	-14,000	1,252,000	318,000	558,000	3,509,000	126,000	554,000	915,000	599,000	488,000	11,798,000	247,000	76,000	282,000	525,000	9,000	430,000	2,044,000	82,000	-46,000	4,359,000
amortization of right of use assets	3,675,000	3,813,000	5,744,000	4,567,000	4,452,000	4,427,000
other non-cash expense	1,988,000	939,000	-434,000	1,295,000	-25,000	219,000	-4,218,000	-757,000	2,175,000	229,000	2,919,000	-1,274,000	-1,225,000	1,000	365,000	102,000	-285,000	377,000	1,242,000				576,000			165,000																								46,000	30,000	4,000	142,000			70
changes in assets and liabilities, net of effect of acquisitions:
accounts receivable	-22,299,000	4,328,000	4,522,000	-5,414,000	-27,416,000	-359,000	-18,619,000	7,969,000	29,434,000	34,320,000	-3,012,000	44,530,000	16,925,000	23,635,000	-19,500,000	-33,305,000	7,004,000	-1,219,000	-28,997,000	-20,721,000	-7,215,000	4,417,000	-13,330,000	1,138,000	-1,687,000	-3,646,000	5,538,000	-22,078,000	3,681,000	2,760,000	-10,940,000	7,323,000	-21,328,000	19,754,000	11,207,000	-12,894,000	-13,539,000	19,452,000	-1,336,000	-15,496,000	2,525,000	9,161,000	1,387,000			1,522,000				8,579,000	10,121,000	2,892,000			6,205,000	17,435	2,330,000	14,042,000
inventories	-30,212,000	-6,626,000	978,000	-2,082,000	11,527,000	18,570,000	28,628,000	19,162,000	-18,459,000	-867,000	16,086,000	4,368,000	6,852,000	-9,501,000	6,744,000	-25,189,000	-43,550,000	-16,128,000	-15,486,000	-895,000	-1,651,000	6,613,000	-12,081,000	-22,564,000	-17,350,000	-3,713,000	4,043,000	-4,103,000	1,399,000	4,715,000	3,372,000	-3,120,000	-4,845,000	-2,297,000	4,336,000	-1,159,000	-1,030,000	2,113,000	1,954,000	-6,760,000	-7,632,000	2,671,000	-7,810,000					1,114,000	1,207,000	7,416,000				1,217,000	667,000	1,531	3,953,000
prepaid expenses and other assets	-2,419,000	-10,655,000	1,915,000	-1,953,000	-6,062,000	-3,577,000	-2,005,000	7,662,000	-4,870,000	-3,418,000	5,747,000	-1,665,000	8,793,000	1,199,000	1,017,000	-2,519,000	1,171,000	-6,364,000	-465,000	-268,000	-75,000	-3,559,000	-46,000	48,000	-1,306,000	-3,551,000	19,145,000	-7,272,000	-5,271,000	-8,650,000	23,533,000	-3,759,000	1,117,000	-9,256,000	20,064,000	282,000	-5,937,000	-4,281,000	15,887,000	-11,102,000	-2,758,000	-7,321,000	15,278,000														1,883,000	1,947,000
other long-term assets	11,780,000	-2,723,000	-2,547,000	-3,022,000	9,575,000	-2,071,000	-4,124,000	-740,000	5,602,000	-3,471,000	-2,210,000	-639,000	-32,000	2,332,000	-2,323,000	-1,616,000	-388,000	-3,365,000	557,000	-1,027,000	-1,209,000	-1,083,000
accounts payable	8,221,000	-4,079,000	-1,947,000	13,590,000	31,768,000	-912,000	-6,529,000	4,827,000	9,100,000	789,000	-9,942,000	-4,416,000	-5,538,000	4,736,000	-13,220,000	-10,103,000	8,911,000	4,676,000	1,741,000	-2,137,000	7,233,000	1,439,000	-89,000	2,308,000	11,768,000	-4,252,000	359,000	84,000	5,915,000	-5,358,000	1,560,000	-1,785,000	3,588,000	-5,658,000	-4,371,000	490,000	10,442,000	-445,000	-9,343,000	214,000	3,401,000	-4,715,000	-4,991,000	-242,000	2,385,000	2,687,000	3,844,000	3,331,000	1,752,000				-2,994,000				2,750,000	1,969,000
income taxes payable/receivable	6,315,000	-1,805,000	10,750,000	2,180,000	6,329,000	13,306,000	8,618,000	-7,519,000	-23,676,000	-2,447,000	-4,516,000	-86,221,000	-7,350,000	-21,842,000	-9,246,000	-11,095,000	-8,936,000	29,751,000	38,501,000	15,465,000	14,282,000	-1,428,000	10,143,000	-8,738,000	1,404,000	4,575,000	5,041,000	-1,929,000	-2,594,000	-7,277,000	2,435,000	-9,334,000	-113,000	-4,361,000	3,226,000	-23,703,000	313,000	-410,000	9,349,000	3,616,000	-11,677,000	-8,210,000	-6,748,000	4,714,000									7,127,000	534,000	1,230,000
operating lease liabilities	-3,699,000	-3,935,000	-6,213,000	-3,973,000	-4,760,000	-4,090,000	-3,622,000	-3,953,000	-4,512,000	-3,877,000
other current liabilities	8,640,000	-36,447,000	8,018,000	7,771,000	31,889,000	6,766,000	4,209,000	-5,289,000	7,951,000	-7,856,000	3,582,000	3,934,000	14,000	-20,685,000	26,814,000	-28,059,000	-2,239,000	-39,336,000	7,609,000	-7,197,000	29,135,000	17,911,000	26,142,000	698,000	8,949,000	-5,128,000	-13,554,000	-2,717,000	14,749,000	7,145,000	-20,524,000	5,614,000	9,080,000	5,250,000	-20,087,000	-91,000	4,937,000	4,056,000	-17,597,000	10,758,000	4,589,000	-3,110,000	-12,394,000	248,000	19,608,000	1,250,000	17,328,000	12,444,000	7,409,000				9,739,000	2,249,000	2,536,000
other long-term liabilities	-14,341,000	-1,974,000	1,638,000	4,248,000	-10,074,000	122,000	5,352,000	5,759,000	-5,736,000	3,968,000	13,957,000	2,180,000	440,000	-832,000	36,000	2,024,000	-125,000	2,588,000	-2,415,000	3,678,000	721,000	1,330,000	1,887,000	3,144,000	-2,922,000	1,843,000	-1,376,000	1,412,000	-732,000	816,000	1,178,000	1,028,000	-600,000	3,301,000	277,000	1,577,000	-773,000	821,000	1,526,000	-728,000	-767,000	676,000	-1,618,000	1,752,000	-22,000	2,431,000			1,196,000						1,356,000	2,307
net cash from operating activities	26,728,000	12,081,000	69,853,000	71,404,000	-143,250,000	74,931,000	46,843,000	54,292,000	45,731,000	60,041,000	46,037,000	9,041,000	75,012,000	51,311,000	103,118,000	194,000	67,819,000	64,980,000	98,834,000	90,923,000	111,718,000	82,641,000	50,678,000	9,067,000	31,292,000	14,262,000	55,623,000	-11,579,000	49,363,000	31,051,000	26,482,000	20,479,000	15,741,000	28,677,000	48,763,000	-3,665,000	23,101,000	47,323,000	21,060,000	10,965,000	16,611,000	16,135,000	32,442,000	18,390,000	5,875,000	29,969,000	22,160,000	28,579,000	17,600,000	11,021,000			14,946,000	15,564,000	13,077,000	28,734	20,522,000	29,640,000			25,358,000				203,000
capex	-18,118,000	-16,884,000	-22,067,000	-23,451,000	-21,972,000	-15,073,000	-16,483,000	-13,037,000	-23,903,000	-11,496,000	-22,772,000	-18,986,000	-18,388,000	-23,137,000	-24,767,000	-21,039,000	-21,268,000	-23,683,000	-18,422,000	-15,809,000	-14,153,000	-15,390,000	-21,017,000	-12,054,000	-11,491,000	-4,765,000	-5,976,000	-3,977,000	-7,072,000	-5,138,000	-5,528,000	-3,867,000	-7,203,000	-6,792,000	-6,622,000	-4,874,000	-6,591,000	-3,901,000	-5,438,000	-11,038,000	-11,436,000	-8,139,000	-9,669,000	0	0	0	0	0	0	0			0	0	0	0	0	0			0				0
free cash flows	8,610,000	-4,803,000	47,786,000	47,953,000	-165,222,000	59,858,000	30,360,000	41,255,000	21,828,000	48,545,000	23,265,000	-9,945,000	56,624,000	28,174,000	78,351,000	-20,845,000	46,551,000	41,297,000	80,412,000	75,114,000	97,565,000	67,251,000	29,661,000	-2,987,000	19,801,000	9,497,000	49,647,000	-15,556,000	42,291,000	25,913,000	20,954,000	16,612,000	8,538,000	21,885,000	42,141,000	-8,539,000	16,510,000	43,422,000	15,622,000	-73,000	5,175,000	7,996,000	22,773,000	18,390,000	5,875,000	29,969,000	22,160,000	28,579,000	17,600,000	11,021,000			14,946,000	15,564,000	13,077,000	28,734	20,522,000	29,640,000			25,358,000				203,000
cash flows from investing activities:
purchases of property and equipment	-18,118,000	-16,884,000	-22,067,000	-23,451,000	-21,972,000	-15,073,000	-16,483,000	-13,037,000	-23,903,000	-11,496,000	-22,772,000	-18,986,000	-18,388,000	-23,137,000	-24,767,000	-21,039,000	-21,268,000	-23,683,000	-18,422,000	-15,809,000	-14,153,000	-15,390,000	-21,017,000	-12,054,000	-11,491,000	-4,765,000	-5,976,000	-3,977,000	-7,072,000	-5,138,000	-5,528,000	-3,867,000	-7,203,000	-6,792,000	-6,622,000	-4,874,000	-6,591,000	-3,901,000	-5,438,000	-11,038,000	-11,436,000	-8,139,000	-9,669,000
proceeds from dispositions of property and equipment	3,120,000	70,000	439,000	819,000	256,000	1,695,000	21,258,000	-208,000	181,000	695,000	66,000	897,000			1,667,000	2,648,000	64,000	26,000	951,000	858,000	21,000	123,000	133,000	242,000	130,000	50,000	-685,000	874,000	406,000	568,000	168,000	-83,000	318,000	182,000	1,351,000	37,000						26,000	17,000	305,000			509,000	-234,000	478,000	254,000	523,000	826,000	2,199,000	29,000	9,824,000	143	20,000					10,846,000	983,000	77,000	826,000
proceeds from sales and maturities of available-for-sale securities			15,030,000	60,000			41,928,000	115,000	5,000	120,000	1,995,000	9,464,000	-28,000	121,000	-1,000	58,590,000	18,486,000	9,711,000	105,000	5,000	0	25,108,000	188,092,000	65,496,000	28,216,000	51,254,000	76,015,000	94,608,000	98,066,000	77,370,000	46,145,000	60,939,000	34,741,000	51,605,000	38,709,000	43,247,000	34,879,000	128,526,000	25,924,000	43,906,000	40,682,000	30,188,000	73,028,000	74,233,000	28,803,000	19,506,000	43,863,000	30,780,000	22,506,000	24,930,000	21,322,000	4,112,000	-411,785,000	431,120,000	130,266,000	176,506	80,778,000	80,875,000	103,678,000	51,182,000	95,440,000
net cash from investing activities	-14,998,000	-16,814,000	-6,598,000	-51,382,000	-1,495,000	-13,378,000	11,362,000	-55,027,000	-23,838,000	-10,681,000	-20,711,000	-8,744,000	-20,518,000	-50,320,000	-23,220,000	24,964,000	-65,640,000	-3,840,000	-49,921,000	-15,279,000	-14,295,000	-730,793,000	167,208,000	-42,529,000	-17,623,000	-3,612,000	22,294,000	-5,623,000	-42,524,000	29,020,000	-78,443,000	-14,291,000	-14,820,000	-2,229,000	-24,487,000	-15,009,000	-24,875,000	-6,294,000	-38,565,000	-9,175,000	-104,686,000	9,482,000	5,564,000										5,904,000
cash flows from financing activities:
repayments of short-term borrowings	-444,000	-10,452,000	-463,000	-472,000	-471,000	-468,000	-464,000	-442,000	-1,330,000	-12,238,000	-43,074,000	-20,485,000	-21,759,000	-26,476,000	-25,033,000	-28,763,000	-36,333,000	-622,000	-1,579,000	-540,000	-4,780,000	-23,920,000	0	-5,000,000	-17,632,000	-12,160,000	-14,375,000	-4,869,000	-7,943,000	-11,542,000	-16,408,000	-8,323,000	-15,614,000	-21,154,000	-11,177,000	-6,341,000			0	0
repayments of long-term borrowings	-1,863,000	-1,933,000	-2,038,000	-2,304,000	-2,117,000	-2,104,000	-2,055,000	-1,981,000	-1,928,000	-1,956,000	-1,851,000	-1,884,000	-1,895,000	-1,907,000	-2,307,000	-2,373,000	-76,550,000	-90,363,000	-90,754,000	-52,477,000	-34,178,000	-2,171,000
issuance of common stock under employee stock purchase plans	0	6,566,000
net settlement of restricted common stock	-1,429,000	-37,935,000	-281,000	-830,000	-348,000	-8,903,000	-30,000	-220,000	-124,000	-13,175,000	-12,000	-26,000	-298,000	-14,843,000	-28,000	-42,000	-604,000	-35,646,000	-27,000	-15,000	-420,000	-15,255,000	-29,000	-70,000	-27,000	-5,317,000	-7,000	-60,000	-35,000	-5,200,000	-18,000	-104,000	-31,000	-7,658,000	-7,000	-117,000	0	-4,046,000	-23,000	-83,000	-18,000	-4,413,000	-27,000
net cash from financing activities	-3,736,000	-43,754,000		31,866,000	-2,936,000	-5,579,000	-2,548,000	3,897,000	-1,757,000	-9,478,000	-32,397,000	-23,662,000	-29,557,000	5,101,000	-3,091,000	-97,360,000	-79,169,000	-119,378,000	-89,471,000	-48,590,000	-37,252,000	681,301,000	-2,981,000	18,980,000	-1,999,000	3,204,000	-49,973,000	3,495,000	-7,482,000	-19,061,000			197,000	-850,000	822,000	3,280,000	7,590,000	-23,378,000	273,000	-482,000	4,043,000	-18,833,000	-55,698,000			16,918,000	-10,828,000	10,496,000	2,408,000	754,000	489,000	3,079,000				1,986		1,017,000		4,978,000	1,521,000					5,246,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	-7,788,000	-3,765,000	-8,196,000	-735,000	-6,904,000	12,182,000	5,649,000	6,756,000	-8,418,000	4,035,000	-4,037,000	2,661,000	-2,802,000	-1,799,000	960,000	-5,083,000	761,000	943,000	11,754,000	12,787,000	11,887,000	-13,504,000
net decrease in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash, beginning of period	0	462,521,000		0	0	445,520,000		0	0	318,661,000		0	0	324,045,000		0	0	457,087,000		0	0	354,347,000
cash, cash equivalents and restricted cash, end of period	206,000	410,269,000		51,153,000	-154,585,000	513,676,000		9,918,000	11,718,000	362,578,000		-20,704,000	22,135,000	328,338,000		-77,285,000	-76,229,000	399,792,000		39,841,000	72,058,000	373,992,000
non-cash investing and financing activities:
unpaid property and equipment purchases	-1,723,000	5,136,000	-1,569,000	1,083,000	-2,291,000	6,914,000	-2,930,000	46,000	-1,990,000	7,770,000	-579,000	-366,000	-731,000	6,082,000	823,000	1,991,000	-491,000	3,853,000	1,247,000	-772,000	-1,362,000	4,084,000	954,000	-1,262,000	2,301,000	1,499,000	484,000	113,000
net increase in cash, cash equivalents and restricted cash		-52,252,000	52,277,000	51,153,000	-154,585,000	68,156,000	61,306,000	9,918,000	11,718,000	43,917,000	-11,108,000	-20,704,000	22,135,000	4,293,000	77,767,000	-77,285,000	-76,229,000	-57,295,000	-28,804,000	39,841,000	72,058,000	19,645,000
impairment of goodwill							0	0																																										0	0	19,286,000
impairment of long-lived assets							0	0
impairment of investment							0	0																			0
non-cash loss on or laser dissolution
non-cash pension impact
purchases of available-for-sale securities							-35,341,000	-41,897,000			0	-119,000	-6,433,000	-5,000,000	-119,000	-21,485,000	-17,944,000	-14,894,000					0	-96,213,000	-34,478,000	-50,151,000	-37,760,000	-97,128,000	-133,924,000	-43,780,000	-119,228,000	-71,280,000	-42,676,000	-47,224,000	-57,925,000	-53,419,000	-53,257,000	-63,630,000	-55,644,000	-42,043,000	-133,906,000	-12,593,000	-58,273,000
acquisition of businesses, net of cash acquired			0								0	0	0	-18,881,000	0	0			0	0	0	-740,481,000													0	0	0	-67,289,000					481,000
investment at cost											0	0	0	-3,423,000
short-term borrowings							0	0	551,000	12,144,000	12,540,000	18,630,000	20,300,000	68,124,000	24,277,000	28,143,000	34,318,000	2,354,000	1,261,000	672,000	3,010,000	3,920,000	0	20,000,000	17,632,000	17,160,000	14,375,000	4,869,000	7,943,000	11,542,000	15,596,000	9,159,000	15,614,000	21,154,000	11,177,000	6,341,000			0	0	4,476,000	4,786,000	793,000	687,000	579,000	285,000				4,000												1,000	0	34,000	676,000	3,963,000
long-term borrowings			0
issuance of common stock under employee stock option and purchase plans			0	6,587,000	0	5,896,000	1,000	6,540,000	1,074,000	5,747,000	0	6,107,000	0	5,704,000	0	5,675,000	0	4,899,000	0	4,245,000	0	3,866,000	600,000	3,563,000	165,000	3,521,000	52,000	3,555,000	264,000	3,437,000	172,000	3,475,000	228,000	6,810,000	833,000	3,402,000	7,594,000	4,712,000	1,751,000	3,817,000	3,152,000	4,568,000	2,288,000	6,463,000	8,638,000	17,331,000	5,806,000	10,777,000	2,833,000	1,130,000	1,000	3,543,000	1,535,000			3,784
repurchase of common stock											0	-26,004,000	-25,905,000	-25,501,000	0												-50,018,000	0	-7,711,000	-17,298,000									0	-4,334,000	0	-20,665,000	-58,699,000
net cash provided (used in) financing activities
cash, cash equivalents and restricted cash, beginning of year
cash, cash equivalents and restricted cash, end of year
supplemental disclosure of cash flow information:
cash paid during the year for:
interest																																			104,000	37,000	11,000	12,000	15,000	64,000	4,000	3,000	51,000	44,000	2,000	11,000	152,000	16,000	38,000	42,000	29,000	75,000	367,000	94,000	98,000		546,000	1,104,000	1,555,000	149,000	1,494,000
income taxes																																			10,577,000	30,993,000	6,327,000	6,150,000	4,333,000	2,635,000	16,969,000	25,818,000	1,085,000	4,775,000	7,458,000	3,973,000	3,725,000	2,259,000	3,279,000	4,804,000	2,586,000	10,443,000	4,183,000	5,129,000	5,145,000		2,162,000	2,481,000	2,536,000	1,282,000	3,184,000
cash received during the year for:
noncash investing and financing activities:
proceeds from sale of discontinued operation															0	0	0	25,000,000
proceeds from sale of other entities															0
other															0	0																																									63,000	684,000	1,271,000	347,000	170,000		-370,000	-72,000	523,000
amortization of operating right of use assets								4,046,000	3,996,000	4,104,000
gain on business combination																			0	0	0	-5,416,000
impairment and other charges
excess tax benefits from stock-based compensation arrangements																																							-1,451,000	122,000	912,000	1,681,000	743,000	1,121,000	1,569,000	1,678,000	137,000	382,000	100,000	2,000	0	8,000				77
cash flows from discontinued operations																		2,000	-3,973,000	383,000	-18,000	-1,283,000
coherent, inc. and subsidiariesconsolidated statements of cash flows
proceeds from long-term borrowings																			0	0	0	740,685,000
cash paid to subsidiaries' minority shareholders																			0	0
debt issuance costs																			0	-475,000	-68,000	-25,824,000	-2,672,000	-393,000
use of previously owned equity shares in acquisition																			0	0	0	20,685,000
non-cash pension benefit
cash paid to subsidiaries’ minority shareholders
impairment of assets held for sale
increase in cash overdraft
other non-cash incomes
other non-cash expenses																						456,000
other assets																							-975,000	-2,561,000	3,031,000	-1,047,000	1,472,000	-1,252,000	1,240,000	-658,000	-775,000	-647,000	51,000	-2,118,000	569,000	-1,473,000	1,604,000	-666,000	-1,363,000	856,000	1,151,000	-497,000	2,911,000							-2,284,000	3,323,000	6,722,000	-1,153,000
net change in capital lease obligations																																		-2,000				-4,000		-4,000	-3,000	-4,000
effect of exchange rate changes on cash and cash equivalents																							35,000	-3,287,000	3,163,000	-2,118,000	-475,000	1,764,000	-13,696,000	-2,807,000	-5,732,000	-1,078,000	758,000	2,333,000	4,035,000	3,101,000	-208,000	2,584,000	2,413,000	-4,792,000	2,434,000	-6,183,000	-14,928,000	-4,410,000									428,000	12,761,000	1,128,000	3,482	1,397,000	2,151,000	-313,000	-277,000	2,283,000	54,000	2,198,000	2,332,000	2,279,000
net increase in cash and cash equivalents																							214,940,000	-17,769,000	14,833,000	11,736,000	27,469,000	-11,943,000	-14,339,000	38,203,000	-58,351,000	9,317,000	1,876,000	27,931,000	29,133,000	-12,293,000	5,608,000	20,235,000				601,000	-32,620,000												4,868,000		10,753,000	17,590,000	6,398,000	-4,973,000	11,502,000					4,759,000
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
cash and cash equivalents, beginning of period																								0	0	130,607,000		0	0	91,217,000		0	0	110,444,000		0	0	67,761,000		0	0	167,061,000		0	0	245,380,000	0	0	199,950,000	0	0	213,826,000	0	0	315,927,000	445,231	97,507,000	87,659,000	0	0	76,541,000		0	0	131,018,000	77,409,000
cash and cash equivalents, end of period																								-17,769,000	14,833,000	142,343,000		-11,943,000	-14,339,000	129,420,000		9,317,000	1,876,000	138,375,000		-12,293,000	5,608,000	87,996,000		-3,484,000	-81,598,000	167,662,000		-436,000	-27,398,000	227,515,000	18,185,000	-7,594,000	199,760,000	-620,000	-2,284,000	185,235,000	24,347,000	-151,011,000	320,795,000	434,826	108,260,000	105,249,000	6,398,000	-4,973,000	88,043,000		-8,036,000	-19,337,000	112,002,000	82,168,000
other non-cash income																											518,000	-376,000	24,000	360,000	-988,000	-354,000	10,000	-32,000	-130,000	183,000	-222,000	522,000	-567,000	252,000	-266,000	154,000
cash dividend paid
write-off of hypertronics intangibles
excess tax benefit from stock-based compensation arrangements																																							1,451,000	-122,000	-912,000	-1,681,000	-743,000
repayments of capital lease obligations
capital lease repayments																																0				-5,000
cash dividend paid on common stock																																				0	0	-24,040,000
net cash provided by/(used in) financing activities
non-cash translation adjustment related to finland dissolution
change in restricted cash																																																		0	0	2,521,000
loss on disposal of property and equipment																																							-337,000	360,000	170,000	42,000	61,000	-328,000	411,000	156,000	118,000	233,000	100,000
cash paid during the period for:
cash received during the period for:
unpaid property and equipment																																				797,000	53,000	1,000,000		-2,166,000	1,844,000	1,933,000		-1,846,000	1,939,000	889,000	-176,000	306,000	654,000	-310,000	-62,000	1,554,000	-410,000	1,551,000	872,000
investment in sionyx
other-net
assets acquired under capital leases
tax benefit from employee stock options																																								2,572,000	564,000	955,000	-6,000	48,000	-1,295,000	1,543,000
changes in restricted cash
net decrease in cash and cash equivalents																																								-3,484,000
repayments of short-term borrowing																																										-4,786,000
non-cash gain on finland dissolution
short-term repayments
cash overdrafts decrease
acquisition of businesses
non-cash restructuring and other charges																																															146,000	904,000	230,000
repayment of capital lease obligations
acquisition of a business
gain on disposal of property and equipment																																																		58,000	283,000	155,000
non-cash restructuring and other																																																		209,000
proceeds from sale of business																																																					0	0	6,519,000
other—net																																																					-518,000	75,000	729,000	196										1,340,000
cash overdrafts increase																																																									831,000		216,000						786,000
retirement of restricted common stock
net retirement of restricted stock awards																																																		327,000	370,000	24,000
purchased in-process research and development																																																									690,000
(gain) loss on disposal of property and equipment
amortization of bond issue costs																																																								292
premiums paid for life insurance contracts
long-term debt repayments
collection of notes receivable from common stock
portion of deferred business acquisition costs included in other current liabilities
unrealized loss on equity securities
repayment of capital lease obligation
excess tax benefits from stock-based payment arrangements																																																									172,000
changes in operating assets and liabilities, net of acquisitions:
income taxes payable
decrease in restricted cash and cash equivalents
deferred business acquisition costs
premiums paid on life insurance
other – net
proceeds received from issuance of convertible subordinated notes
long-term debt borrowings																																																														3,000	23,000	49,000	288,000	8,000
long-term debt payments
sales of shares under employee stock plans																																																									3,596,000	3,584,000	2,482,000	2,124,000	2,317,000		7,432,000	472,000	2,921,000	4,201,000
collection of notes receivable from stock sales																																																										35,000				0	348,000	718,000	186,000	66,000
non-cash restructuring, impairment and other charges																																																										300,000
increase in restricted cash and cash equivalents																																																									4,000
other — net
tax benefit from stock option exercises																																																									60,000	225,000	164,000	417,000	78,000			134,000	200,000
portion of iolon purchase price not yet paid																																																									512,000
cash flows from continuing operating activities:
income from continuing operations
adjustments to reconcile income from continuing operations to net cash from continuing operating activities:
stock based compensation
minority interest in subsidiaries’ losses
equity in loss of joint ventures
gain on sale of joint venture
gain on sale of lumenis investment
write-down of lumenis investment																																																														0	0	0	10,212,000
purchases of short-term trading investments
proceeds from sales of short-term trading investments																																																																93,998,000	84,243,000	26,600,000
issuance of common stock under productivity incentive plan
dividends paid to minority stockholders
net cash from continuing operating activities																																																											16,442,000							11,137,000
cash flows from continuing investing activities:
proceeds from sale of note receivable from picometrix
acquisition of businesses and minority interest, net of cash acquired
change in restricted cash, cash equivalents and short-term investments
premiums paid for life insurance
distributions from deferred compensation plan arrangements
investment in joint venture
proceeds from sale of joint venture
net cash from continuing investing activities
cash flows from continuing financing activities:
net cash from continuing financing activities
net cash from discontinued operating activities
net issuances of restricted stock awards
gain on sale of lumenis common stock
intangible assets amortization																																																										1,493,000	1,504,000	1,770,000	1,929,000
changes in operating assets and liabilities:
increase in restricted cash, cash equivalents and short-term investments
proceeds from dispositions of property and equipment and assets held for sale																																																											1,069,000	700,000	534,000
acquisition of businesses and minority interests, net of cash acquired
cash paid during the quarter for:
cash received during the quarter for:
adjustments to reconcile net income from continuing operations to net cash from continuing operating activities:
proceeds from sales and maturities of short-term trading investments
write-down of notes receivable from picometrix																																																															0	0	3,723,000
in-process research and development
changes in operating assets and liabilities																																																											6,846,000	-11,532,000	14,788,000
net cash from discontinued operations																																																											0
portion of purchase price related to pli acquisition included in other current liabilities
net income from continuing operations
decrease in restricted cash, cash equivalents and short-term investments																																																												-8,000	624,000
consolidation of picometrix under fin 46r
income from continuing operations after accounting changes																																																																		2,730,000
adjustments to reconcile income from continuing operations after accounting changes to net cash from continuing operating activities:
cumulative effect of accounting changes
intangibles amortization																																																																947,000	835,000	908,000
minority interest in subsidiaries’ earnings
equity in (income) loss of joint ventures
changes in assets and liabilities:
proceeds from sale of medical segment
issuance of note receivable from picometrix
equipment acquired under capital leases
issuance of notes related to sale of common stock
repayment of acquisition obligation through issuance of common stock
activity resulting from sale of medical segment:
shares of lumenis common stock received
note receivable from lumenis
stock-based compensation charge
deferred income tax expense
adjustments to reconcile income from continuing operations to net cash from operating activities:
restructuring and impairment charges																																																															339,000	405,000	16,438,000
goodwill impairment																																																															0
restricted cash
purchases of available-for-sale investments
proceeds from sales and maturities of available-for-sale investments
acquisition of business, net of cash acquired
other - net																																																																509,000	978,000
adjustments to reconcile income from continuing operations after accounting changes to net cash from operating activities:
other adjustments																																																																		634,000
cash overdrafts

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.